Synaptogenix Inc (SNPX)

[bellweather1]

Certainly a reasonable, though, as you say, thoroughly speculative, explanation of why this outcome diverged so dramatically from the PH2A data(and everything else).

The majority of these patients, as you would expect, could very well have been on namenda for years, and receptor alterations that resulted may have rendered the 30day washout either insufficient, or, even beside the point, if such were not easily and/or completely reversible.

But, again, as you note, we will probably have a long wait to get any inkling one way or the other

By the way, thanks for this response and all of your excellent commentary over the course of the preceding months!

Also, thanks to all the other quality commentators-this is, regardless of the current outcome, an exceptional board!